Geneoscopy is a brand that is dedicated to transforming gastrointestinal health. They offer a range of products and services that focus on improving gastrointestinal disease detection, treatment, and monitoring. The company was co-founded by Andrew Barnell, who has an MBA, and Erica Barnell, who has an MD/PhD.

The idea for Geneoscopy arose when Dr. Erica Barnell encountered a patient with advanced colorectal cancer who had never undergone a colonoscopy due to the inconvenience and burden it posed. Combining their expertise in science and business, the siblings created Geneoscopy with a mission to make a difference in the lives of patients with gastrointestinal diseases.

Geneoscopy's pioneering work led to the development of their first product, a noninvasive colorectal cancer screening test that uses RNA biomarkers in stool samples. With a commitment to innovation and patient care, Geneoscopy is revolutionizing the field of gastrointestinal health